Eppendorf DualChips® Meet FDA Support Quality Demands

Eppendorf DualChips® meet FDA supported “quality control metrics” of the MicroArray Quality Control Project (MAQC). “All commercial microarray platforms tested performed with good intra- and inter-laboratory repeatability and showed similar differential expression results” said Thomas Kolzau, Eppendorf Executive Director of Portfolio Management for Microarrays. The corresponding data will be published in the September issue of Nature Biotechnology.

The MAQC project involves FDA Centers, major providers of microarray platforms and RNA samples, EPA, NIST, academic laboratories, and other stakeholders. The purpose of the project is to provide quality control tools for the microarray community in order to avoid procedural failures and to develop guidelines for microarray data analysis.

Eppendorf participated in the MAQC project with their DualChip microarray platform. DualChips are ready to use microarray kits with topic specific content and well-defined sets of relevant key genes. “We are encouraged by the MAQC results. The DualChip results successfully demonstrate the well known Eppendorf product quality. In combination with the ease of use concept, DualChips enable a standardized microarray workflow at all different levels of expertise” said Thomas Kolzau. Customized gene expression DualChips are also available based on individual needs. Further information may be found at www.eppendorf-biochip.com.

Source: Eppendorf